Veos Pharmaceuticals develops validated human health platforms spanning natural health products, muscle health innovation, and advanced ophthalmic care solutions.
Veos Pharmaceuticals maintains a portfolio of Health Canada–approved Natural Health Products currently commercialized across North America. The platform provides a validated, revenue-generating foundation, supported by established direct-to-consumer and retail distribution channels.
ThymoTropin™ is a clinically driven platform targeting muscle preservation, metabolic health, and age-related decline. The technology is supported by preclinical and clinical evaluation and is positioned for global expansion through regulatory and partnership pathways.
The Ophthalmic Care Platform includes a portfolio of advanced eye care formulations designed to address dryness, irritation, and digital eye strain. These products are developed as medical device formulations and are commercialized across international markets through direct-to-consumer and retail channels.
CopperHeal™ is a copper-based antimicrobial platform designed to support skin protection, wound care, and infection control across consumer and medical applications. The platform leverages the well-established antimicrobial properties of copper to deliver effective, scalable solutions across multiple use cases and markets.